Buenos Aires, Argentina

Ana Romo

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Fundocion Articula, Inis Biotech LLC, Onsejo Nacional De Investigation Cientiticay Tecnica. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ana Romo. Retrieved from https://idiyas.com/inventor/ana-romo-qvc8f0g8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Spirit of Ana Romo

Introduction

Ana Romo, an accomplished inventor based in Buenos Aires, Argentina, has made her mark in the field of biomedical innovations. With a focus on the TGF-beta receptor and its applications in cancer treatment, her work exemplifies the critical intersection of science and technology. Her dedication to research and development has led her to secure a patent that holds promise for medical advances.

Latest Patents

Ana Romo is the proud inventor of a patent titled "TGF-receptor II isoform, fusion peptide, methods of treatment and methods in vitro." This innovative patent involves an isoform of the TGF-beta receptor II that comprises a sequence of approximately 80 amino acids, specifically designed to lack a transmembrane domain. The patent describes the molecular details of the isoform, including its amino acid sequences and their potential applications in treating cancer and hepatic fibrosis. Notably, the invention also includes a fusion peptide that combines the receptor isoform with a ligand and an antibody designed to bind the soluble isoform of the TGF-beta II receptor for use in in vitro methods.

Career Highlights

Ana has built a notable career in research, contributing to prominent institutions that focus on scientific advancement. She has been associated with the National Scientific and Technical Research Council (Consejo Nacional De Investigación Científica y Técnica) and Fundación Articula, both of which have provided her with the platform to explore her groundbreaking research on TGF-beta receptors and their therapeutic applications.

Collaborations

Throughout her career, Ana has collaborated with talented researchers, including Anabela Belen La Colla and Matias Adan Preisegger. These collaborations have enriched her research and led to significant contributions in the fields of biotechnology and medical sciences. Working alongside accomplished peers has enabled her to expand her horizons and enhance her innovative potential.

Conclusion

Ana Romo stands as a testament to the power of innovation in science. Her patented work on the TGF-beta receptor and its applications in cancer treatment highlights the importance of research and collaboration in the pursuit of medical breakthroughs. As she continues her contributions to the field, Ana remains an inspiring figure for aspiring inventors and researchers alike, demonstrating the transformative impact that a single inventor can have in addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…